A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics.

ABSTRACT:

Purpose

We aim to assess the reporting of key patient-level demographic and clinical characteristics among COVID-19 related randomized controlled trials (RCTs).

Methods

We queried English-language articles from PubMed, Web of Science, clinicaltrials.gov, and the CDC library of gray literature databases using keywords of "coronavirus," "covid," "clinical trial" and "randomized controlled trial" from January 2020 to June 2021. From the search, we conducted an initial review to rule-out duplicate entries, identify those that met inclusion criteria (i.e., had results), and exclude those that did not meet the definition of an RCT. Lastly, we abstracted the demographic and clinical characteristics reported on within each RCT.

Results

From the initial 43 627 manuscripts, our

SUBMITTER: Pak J 

PROVIDER: S-EPMC9538362 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature